NIH at AIDS 2022

The National Institutes of Health (NIH) joined the world's largest gathering on HIV/AIDS at the 24th International AIDS Conference (AIDS 2022). Taking place both online and in person, AIDS 2022 presented an opportunity to showcase HIV research around the globe, innovative approaches to HIV prevention and care, and the U.S. government’s ongoing commitment to ending HIV at home and abroad.

Scientific discovery has yielded advances in HIV research that were unavailable and even unimaginable just a decade ago. HIV and HIV-related research has been shaped by people with lived experience, communities affected by HIV, domestic and global cooperation among governments, private industry, and academic and research institutions. New developments in HIV research, prevention, care, and treatment have contributed to reducing HIV transmission, enabling individuals with HIV to live long and healthy lives, while also addressing HIV stigma in communities and health care systems.

AIDS 2022 underscored the value of NIH HIV research and its overall impact on public health for those living with, or affected by, HIV. Find out more through the resources below.

NIH OAR Blog Entries

NIH HIV Research – Highlights at AIDS 2022

Addressing HIV-related Intersectional Stigma and Discrimination

Video Interviews with HIV.gov

Bidirectional learning: A Conversation with Ambassador Dr. John Nkengasong and Dr. Goodenow – Ambassador Dr. John Nkengasong, U.S. Global AIDS Coordinator, and Dr. Maureen Goodenow, Director of the NIH OAR, discuss the role that bidirectional learning plays in reaching and sustaining HIV epidemic control in the U.S. and abroad.

 

AIDS 2022 – Day 2 Daily Summary – In this video summary of the second day of the conference, Dr. Goodenow comments on the need to include people with HIV in research design and health communications. Also featured in an HIV.gov blog post.

 

Day 3 Highlights: Research, Implementation, and Community Engagement – In this interview, Harold Phillips, ONAP Director, and Dr. Goodenow share key learnings from the first three days of the conference, including the development of new modalities for treatment and technological platforms used to deliver new products. HIV.gov included clips in its Day 3 video and a blog on its website.

 

AIDS 2022 – Observations from a Site Visit with Dr. Goodenow & Harold Phillips – Mr. Phillips and Dr. Goodenow react to a site visit to co-located community-based HIV clinics in Montreal with Adm. Rachel Levine. HIV.gov included this video in a blog on its website.

 

NIH Sessions

NIH-sponsored HIV/AIDS research was an integral aspect of formal presentations and informal discussions throughout the conference. More than 100 presentations highlighted NIH-funded research fueling advances in implementation science, HIV-related stigma and discrimination, cure, vaccine development, and more.

Examples of sessions involving NIH staff include:

  • A workshop, organized by National Institute of Mental Health (NIMH) staff, on advancing HIV health communication science to improve messaging among key populations, with remarks by NIH OAR staff
  • A satellite session, co-organized by NIMH and NIH OAR staff, to launch a special issue of the American Journal of Public Health highlighting innovative theory and research on HIV-related intersectional stigma and discrimination
  • A satellite session on implementation science tied to a special issue of the Journal of Acquired Immune Deficiency Syndromes
  • A satellite session, organized by NIMH, on the role of behavioral economics and conditional incentives in strengthening HIV treatment and prevention
  • A workshop on infants, children, and adolescents with perinatal HIV exposure, moderated by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • A session on current approaches to HIV vaccine and cure research, co-moderated by the National Institute of Allergy and Infectious Diseases (NIAID)
  • A satellite session on ethical considerations and community engagement for experimental medicine trials in Africa, with a panelist from NIAID.

Anthony S. Fauci, M.D., Director of NIAID, delivered a plenary address, where he discussed approaches for HIV cure and vaccine research. In comments to HIV.gov, Dr. Fauci charted the history of HIV vaccine development efforts, pointing out the difficulty in eradicating the virus from reservoirs even after the virus has been suppressed to undetectable levels.

Archive: NIH OAR Resources for AIDS 2022

This page last reviewed on August 29, 2022